Get started
Novartis AGNovartis AGNovartis AG

Novartis AG

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

NVSEF trade ideas

Novartis AG (NOVN)The Swiss-based drugmaker missed consensus expectations on both earnings and sales in the first quarter, the results were hurt by a historically weak cough and cold season. Novartis’ cornerstone innovative medicines division turned in with sales +4%. Stock is currently pegged to underperform the broader market and our 18-month projections reflect below-average upside potential. But as said in the chart, a "buy and hold" strategy give a 3.50% dividend yield in CHF.
SIX:NOVN
by mgiuliani
1
NOVARTIS AG, NVS - 4.0% in 35 daysI understand the euphoria of picking on a winning horse and getting returns in excess of or even more than 100%, but what you need to pay attention to is money management and managing your positions. You can buy stocks, you can buy futures, you can buy bonds and you can buy and/or sell options. The key is always to use the instruments that we feel confident in and to have the ideal timing. It is never just one of these two individually. In this case, we have opened a position in our portfolio on Novartis (NVS), which will surely generate us a 4% return within a month. Our goal is always a monthly return between 4%/5% monthly which on a compound growth we get an average of 50%/60% annually. NYSE:NVS
NYSE:NVS
by SwissTradingSchool
Should re-test $98 in 2021NVS is a long term reliable dividend paying hold, but I try to be careful with pharmas. A lot of possible catalysts that can change the direction too soon. This is purely a trend line analysis. I see good indicators from trend lines in play and looks like the stock will re test the $98 high again before either a move up or down. I expect it to break downward by 2022. Caution: slow moving stock. It won't bleed your portfolio on red days, but watching paint dry would be a lot quicker than watching NVS go up a few percentage. Good luck!
NYSE:NVSLong
by Karam08
NVS (NYSE) - Go DownGreetings Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox). Pra Trading : - Please care for Money Management - Have a good psychology - Do not be hurry to open position and do not do nothing if u see opportunity - Evaluate and upgrade your trading plan Execution Strategy : - Know what you want to buy, see the Fundamental - Decide that you are on investing or speculating - Consider what your strategy based on Investing/Speculating - Make Road Map Of Your Trading Plan - Decide a. Entry strategy b. Cut loss c. Target of Profit Post Trading : a. Do not be sad if you loss or do not be very happy if you win b. Just become a normal without emotion, Do not put emotion into your trading c. Evaluate your trading d. Keep on Learning e. Be Humble Idea : NVS (NYSE) - Go Down
NYSE:NVS
by MultiAssetX
NOVN.vx bearish scenario:We have technical figure Triangle in Swiss company Novartis International AG (NOVN.vx) at daily chart. Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. The Triangle has broken through the support line at 16/10/2020, if the price holds below this level we can have possible bearish price movement with forecast for the next 16 days towards 74.78 CHF. Fundamentals: - Swiss drugmaker Novartis grabbed a key European panel’s recommendation for its prospective cholesterol drug Leqvio on Friday, clearing the way for its approval in the next couple of months. Novartis is also counting on approval from U.S. regulators before the end of the year for the drug, also known as inclisiran, which the Basel-based drugmaker bought in a deal last year for nearly $10 billion and predicts will be a top seller.
SIX:NOVN
by legacyFXofficial